Metformin and gefitinib cooperate to inhibit bladder cancer growth via both AMPK and EGFR pathways joining at Akt and Erk - Concepedia

Concepedia

Publication | Open Access

Metformin and gefitinib cooperate to inhibit bladder cancer growth via both AMPK and EGFR pathways joining at Akt and Erk

DOI Full Paper Access

66

Citations

24

References

2016

Year

Mei Peng, Yanjun Huang, Ting Tao, Caiyun Peng, Qiongli Su, Wanjun Xu, Kwame Oteng Darko, Xiaojun Tao, Xiaoping Yang

Scientific Reports

References

	Year	Citations

Page 1